BEATO, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 262
EU - Europa 215
AS - Asia 85
AF - Africa 2
Totale 564
Nazione #
US - Stati Uniti d'America 260
CN - Cina 63
IE - Irlanda 54
SE - Svezia 52
IT - Italia 40
FI - Finlandia 35
DE - Germania 14
TR - Turchia 13
BE - Belgio 8
AT - Austria 6
IN - India 5
GB - Regno Unito 3
CA - Canada 2
GH - Ghana 2
HK - Hong Kong 2
UA - Ucraina 2
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
Totale 564
Città #
Chandler 88
Dublin 54
Dearborn 23
Parma 22
Ann Arbor 15
Nanjing 13
Izmir 12
Shanghai 11
Bremen 10
Princeton 10
Ashburn 9
Beijing 8
Wilmington 7
Brussels 6
Jacksonville 6
Hefei 5
Kunming 5
Nanchang 5
Pune 5
New York 4
Shenyang 4
Vienna 4
Helsinki 3
Antwerpen 2
Hebei 2
Hong Kong 2
Modena 2
Norwalk 2
Rome 2
San Mateo 2
Toronto 2
Woodbridge 2
Amstelveen 1
Boardman 1
Changsha 1
Fairfield 1
Fremont 1
Guangzhou 1
Haikou 1
Kocaeli 1
Leicester 1
London 1
Milan 1
Redwood City 1
Rockville 1
Seattle 1
Simi Valley 1
Taizhou 1
Turin 1
Viadana 1
Wenzhou 1
Xian 1
Xiangfen 1
Totale 368
Nome #
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 77
Molecular dynamics simulations and docking studies on 3D models of the heterodimeric and homodimeric 5-HT(2A) receptor subtype. 72
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 66
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 63
A High Performance Workflow for Chemistry Driven de Novo Design 59
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 55
Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step towards new anti-excitotoxic agents 51
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients 49
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 49
Use of Experimental Design To Optimize Docking Performance: The Case of LiGenDock, the Docking Module of Ligen, a New De Novo Design Program 45
Totale 586
Categoria #
all - tutte 2.131
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.131


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201915 0 0 0 0 0 0 0 0 0 0 15 0
2019/202078 16 13 1 0 6 19 9 0 3 8 0 3
2020/202131 0 1 1 0 4 2 0 5 9 2 5 2
2021/202250 0 3 3 6 1 0 2 8 3 2 5 17
2022/2023264 29 38 10 28 23 39 4 12 70 0 6 5
2023/202456 3 6 2 3 10 13 8 5 6 0 0 0
Totale 586